Investigational Drug Information for Asimadoline
✉ Email this page to a colleague
What is the drug development status for Asimadoline?
Asimadoline is an investigational drug.
There have been 7 clinical trials for Asimadoline.
The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2010.
The most common disease conditions in clinical trials are Syndrome, Irritable Bowel Syndrome, and Pruritus. The leading clinical trial sponsors are Tioga Pharmaceuticals, RTI Health Solutions, and Charite University, Berlin, Germany.
Summary for Asimadoline
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 740 |
| WIPO Patent Applications | 255 |
| Japanese Patent Applications | 119 |
| Clinical Trial Progress | Phase 3 (2010-05-01) |
| Vendors | 34 |
Recent Clinical Trials for Asimadoline
| Title | Sponsor | Phase |
|---|---|---|
| Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis | Tioga Pharmaceuticals | Phase 2 |
| A Metabolite Identification, Mass Balance, and PK Study of [14C]-Asimadoline to Healthy Adult Male Volunteers | Tioga Pharmaceuticals | Phase 1 |
| Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) | RTI Health Solutions | Phase 3 |
Clinical Trial Summary for Asimadoline
Top disease conditions for Asimadoline
Top clinical trial sponsors for Asimadoline
US Patents for Asimadoline
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
